Equities

AxoGen Inc

AxoGen Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)12.66
  • Today's Change-0.61 / -4.60%
  • Shares traded692.89k
  • 1 Year change+134.44%
  • Beta1.0429
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments314984
Total Receivables, Net252218
Total Inventory231917
Prepaid expenses2.811.941.84
Other current assets, total6.006.256.25
Total current assets8898127
Property, plant & equipment, net1049478
Goodwill, net------
Intangibles, net4.533.652.86
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets197195208
LIABILITIES
Accounts payable128.965.92
Accrued expenses191518
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.010.010.01
Other current liabilities, total------
Total current liabilities302424
Total long term debt474645
Total debt474645
Deferred income tax------
Minority interest------
Other liabilities, total242526
Total liabilities1019495
SHAREHOLDERS EQUITY
Common stock0.430.420.42
Additional paid-in capital377360343
Retained earnings (accumulated deficit)(281)(260)(231)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity96101113
Total liabilities & shareholders' equity197195208
Total common shares outstanding434242
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.